Characterization of mesenchymal stem cells isolated from the rabbit fetal liver

Stem Cells and Development

Volumn 19, Issue 10, 2010, Pages 1579-1588

  Moreno, Rafael ^a   Martínez González, Itziar ^a   Rosal, Marta ^b   Farwati, Abduljalil ^a   Gratacós, Eduard ^c   Aran, Josep M ^a  

^a HOSPITAL DURAN I REYNALS   (Spain)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD86 ANTIGEN; MESSENGER RNA; PHYTOHEMAGGLUTININ; RETROVIRUS VECTOR;

ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW; CARTILAGE CELL; CELL ADHESION; CELL CULTURE; CELL DIFFERENTIATION; CELL GROWTH; CELL ISOLATION; CELL LINEAGE; CELL MATURATION; CELL THERAPY; CLONOGENESIS; CONTROLLED STUDY; CYTOCHEMISTRY; FEMALE; FETUS; FETUS LIVER; GENE EXPRESSION; GENETIC ANALYSIS; IMMUNOREGULATION; LYMPHOCYTE PROLIFERATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MESENCHYMAL STEM CELL; MESODERM; NONHUMAN; NUCLEOTIDE SEQUENCE; OSTEOCYTE; PRIORITY JOURNAL; TRANSGENE;

ANIMALS; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; CELL LINEAGE; CELL SEPARATION; CELLS, CULTURED; FETUS; HUMANS; LIVER; MESENCHYMAL STEM CELLS; RABBITS;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 77957594356     PISSN: 15473287     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.2009.0514     Document Type: Article

References (51)

1. Trounson A. (2009). New perspectives in human stem cell therapeutic research. BMC Med 7:29.
2. Psaltis PJ, AC Zannettino, SG Worthley and S Gronthos. (2008). Concise review: mesenchymal stromal cells: potential for cardiovascular repair. Stem Cells 26:2201-2210.
3. Phillips MI and YL Tang. (2008). Genetic modification of stem cells for transplantation. Adv Drug Deliv Rev 60:160-172.
4. Campagnoli C, IA Roberts, S Kumar, PR Bennett, I Bellantuono and NM Fisk. (2001). Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. Blood 98:2396-2402.
5. Javazon EH, KJ Beggs and AW Flake. (2004). Mesenchymal stem cells: paradoxes of passaging. Exp Hematol 32:414-425.
6. Pittenger MF, AM Mackay, SC Beck, RK Jaiswal, R Douglas, JD Mosca, MA Moorman, DW Simonetti, S Craig and DR Marshak. (1999). Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147
7. Zuk PA, M Zhu, P Ashjian, DA De Ugarte, JI Huang, H Mizuno, ZC Alfonso, JK Fraser, P Benhaim and MH Hedrick. (2002). Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 13:4279-4295.
8. Sanchez-Ramos J., S Song, F Cardozo-Pelaez, C Hazzi, T Stedeford, A Willing, TB Freeman, S Saporta, W Janssen, N Patel, DR Cooper and PR Sanberg. (2000). Adult bone marrow stromal cells differentiate into neural cells in vitro. Exp Neurol 164:247-256.
9. Wakitani S, T Saito and AI Caplan. (1995). Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine. Muscle Nerve 18:1417-1426.
10. Beyth S, Z Borovsky, D Mevorach, M Liebergall, Z Gazit, H Asian, E Galun and J Rachmilewitz. (2005). Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. Blood 105:2214-2219.
11. Corcione A, F Benvenuto, E Ferretti, D Giunti, V Cappiello, F Cazzanti, M Risso, F Gualandi, GL Mancardi, V Pistoia and A Uccelli. (2006). Human mesenchymal stem cells modulate B-cell functions. Blood 107:367-372.
12. Jiang XX, Y Zhang, B Liu, SX Zhang, Y Wu, XD Yu and N Mao. (2005). Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells. Blood 105:4120-4126.
13. Bernardo ME, F Locatelli and WE Fibbe. (2009). Mesenchymal stromal cells. Ann N Y Acad Sci 1176:101-117
14. Caplan AI. (1994). The mesengenic process. Clin Plast Surg 21:429-435.
15. Roobrouck VD, F Ulloa-Montoya and CM Verfaillie. (2008). Self-renewal and differentiation capacity of young and aged stem cells. Exp Cell Res 314:1937-1944.
16. Ilancheran S, Y Moodley and U Manuelpillai. (2009). Human fetal membranes: a source of stem cells for tissue regeneration and repair? Placenta 30:2-10.
17. In't Anker PS, WA Noort, SA Scherjon, C Kleijburg-van der Keur, AB Kruisselbrink, RL van Bezooijen, W Beekhuizen, R Willemze, HH Kanhai and WE Fibbe. (2003). Mesenchymal stem cells in human second-trimester bone marrow, liver, lung, and spleen exhibit a similar immunophenotype but a heterogeneous multilineage differentiation potential. Haematologica 88:845-852.
18. Götherström C, O Ringdén, C Tammik, E Zetterberg, M Westgren and K Le Blan. (2004). Immunologic properties of human fetal mesenchymal stem cells. Am J Obstet Gynecol 190:239-245.
19. Ahn JI, S Terry Canale, SD Butler and KA Hasty. (2004). Stem cell repair of physeal cartilage. J Orthop Res 22:1215-1221.
20. Chang C, D Niu, H Zhou, F Li and F Gong. (2007). Mesenchymal stem cells contribute to insulin-producing cells upon microenvironmental manipulation in vitro. Transplant Proc 39:3363-3368.
21. Choi YS, SN Park and H Suh. (2008). The effect of PLGA sphere diameter on rabbit mesenchymal stem cells in adipose tissue engineering. J Mater Sci Mater Med 19:2165-2171.
22. Planka L, P Gal, H Kecova, J Klima, J Hlucilova, E Filova, E Amler, P Krupa, L Kren, R Srnec, L Urbanova, J Lorenzova and A Necas. (2008). Allogeneic and autogenous transplantations of MSCs in treatment of the physeal bone bridge in rabbits. BMC Biotechnol 8:70.
23. Hildinger M, KL Abel, W Ostertag and C Baum. (1999). Design of 5' untranslated sequences in retroviral vectors developed for medical use. J Virol 73:4083-4089.
24. Moreno R, M Rosal, I Martinez, F Vilardell, JR Gonzalez, J Petriz, E Hernandez-Andrade, E Gratacos and JM Aran. (2008). Restricted transgene persistence after lentiviral vector-mediated fetal gene transfer in the pregnant rabbit model. J Gene Med 10:951-964.
25. Ducy P, R Zhang, V Geoffroy, AL Ridall and G Karsenty. (1997). Osf2/Cbfal: a transcriptional activator of osteoblast differentiation. Cell 89:747-754.
26. Puissant B, C Barreau, P Bourin, C Clavel, J Corre, C Bousquet, C Taureau, B Cousin, M Abbal, P Laharrague, L Penicaud, L Casteilla and A Blancher. (2005). Immunomodulatory effect of human adipose tissue-derived adult stem cells: comparison with bone marrow mesenchymal stem cells. Br J Haematol 129:118-129.
27. Lindton B, L Markling, O Ringdén, A Kjaeldgaard, O Gustafson and M Westgren. (2000). Mixed lymphocyte culture of human fetal liver cells. Fetal Diagn Ther 15:71-78.
28. Daley, GQ and DT Scadden. (2008). Prospects for stem cell-based therapy. Cell 132:544-548.
29. Satija NK, VK Singh, YK Verma, P Gupta, S Sharma, F Afrin, M Sharma, P Sharma, RP Tripathi and GU Gurudutta. (2009). Mesenchymal stem cell-based therapy: a new paradigm in regenerative medicine. J Cell Mol Med. [Epub ahead of print]
30. Kassem M and BM Abdallah. (2008). Human bone-marrow-derived mesenchymal stem cells: biological characteristics and potential role in therapy of degenerative diseases. Cell Tissue Res 331:157-163.
31. Guillot PV, C Gotherstrom, J Chan, H Kurata and NM Fisk. (2007). Human first-trimester fetal MSC express pluripotency markers and grow faster and have longer telomeres than adult MSC. Stem Cells 25:646-654.
32. Lee CC, F Ye and AF Tarantal. (2006). Comparison of growth and differentiation of fetal and adult rhesus monkey mesenchymal stem cells. Stem Cells Dev 15:209-220.
33. Huang CY, PM Reuben and HS Cheung. (2005). Temporal expression patterns and corresponding protein inductions of early responsive genes in rabbit bone marrow-derived mesenchymal stem cells under cyclic compressive loading. Stem Cells 23:1113-1121.
34. Deasy BM, RJ Jankowski, TR Payne, B Cao, JP Goff, JS Greenberger and J Huard. (2003). Modeling stem cell population growth: incorporating terms for proliferative heterogeneity. Stem Cells 21:536-545.
35. Davé UP, K Akagi, R Tripathi, SM Cleveland, MA Thompson, M Yi, R Stephens, JR Downing, NA Jenkins and NG Copeland. (2009). Murine leukemias with retroviral insertions at Lmo2 are predictive of the leukemias induced in SCID-X1 patients following retroviral gene therapy. PLoS Genet 5:e1000491.
36. Fox JM, G Chamberlain, BA Ashton and J Middleton. (2007). Recent advances into the understanding of mesenchymal stem cell trafficking. Br J Haematol 137:491-502.
37. Kode JA, S Mukherjee, MV Joglekar and AA Hardikar. (2009). Mesenchymal stem cells: immunobiology and role in immunomodulation and tissue regeneration. Cytotherapy 11:377-391.
38. Potian JA, H Aviv, NM Ponzio, JS Harrison and P Rameshwar. (2003). Veto-like activity of mesenchymal stem cells: functional discrimination between cellular responses to alloantigens and recall antigens. J Immunol 171:3426-3434.
39. Götherström C, O Ringdén, M Westgren, C Tammik and K Le Blanc. (2003). Immunomodulatory effects of human foetal liver-derived mesenchymal stem cells. Bone Marrow Transplant 32:265-272.
40. Eliopoulos N, J Stagg, L Lejeune, S Pommey and J Galipeau. (2005). Allogeneic marrow stromal cells are immune rejected by MHC class I-and class II-mismatched recipient mice. Blood 106:4057-4065.
41. Poncelet AJ, J Vercruysse, A Saliez and P Gianello. (2007). Although pig allogeneic mesenchymal stem cells are not immunogenic in vitro, intracardiac injection elicits an immune response in vivo. Transplantation 83:783-790.
42. Sakamoto N, K Tsuji, LM Muul, AM Lawler, EF Petricoin, F Candotti, JA Metcalf, JA Tavel, HC Lane, WJ Urba, BA Fox, A Varki, JK Lunney and AS Rosenberg. (2007). Bovine apolipoprotein B-100 is a dominant immunogen in therapeutic cell populations cultured in fetal calf serum in mice and humans. Blood 110:501-508.
43. Spees JL, CA Gregory, H Singh, HA Tucker, A Peister, PJ Lynch, SC Hsu, J Smith and DJ Prockop. (2004). Internalized antigens must be removed to prepare hypoimmunogenic mesenchymal stem cells for cell and gene therapy. Mol Ther 9:747-756.
44. Péault B. (1996). Hematopoietic stem cell emergence in embryonic life: developmental hematology revisited. J Hematother 5:369-378.
45. Chan J, K O'Donoghue, J de la Fuente, IA Roberts, S Kumar, JE Morgan and NM Fisk. (2005). Human fetal mesenchymal stem cells as vehicles for gene delivery. Stem Cells 23:93-102.
46. Kumar S, D Chanda and S Ponnazhagan. (2008). Therapeutic potential of genetically modified mesenchymal stem cells. Gene Ther 15:711-715.
47. Guillot PV, O Abass, JH Bassett, SJ Shefelbine, G Bou-Gharios, J Chan, H Kurata, GR Williams, J Polak and NM Fisk. (2008). Intrauterine transplantation of human fetal mesenchymal stem cells from first-trimester blood repairs bone and reduces fractures in osteogenesis imperfecta mice. Blood 111:1717-1725.
48. Gu T, CX Li, Y Feng, Q Wang, CH Li and CF Li. (2007). Transarterial gene therapy for hepatocellular carcinoma in a rabbit model. World J Gastroenterol 13:2113-2117
49. Huang JL MM Durbhakula, P Angele, B Johnstone and JU Yoo. (2006). Lunate arthroplasty with autologous mesenchymal stem cells in a rabbit model. J Bone Joint Surg Am 88:744-752.
50. Kubo M, S Imai, M Fujimiya, E Isoya, K Ando, T Mimura and Y Matsusue. (2007). Exogenous collagen-enhanced recruitment of mesenchymal stem cells during rabbit articular cartilage repair. Acta Orthop 78:845-855.
51. Sakai D, J Mochida, T Iwashina, T Watanabe, T Nakai, K Ando and T Hotta. (2005). Differentiation of mesenchymal stem cells transplanted to a rabbit degenerative disc model: potential and limitations for stem cell therapy in disc regeneration. Spine 30:2379-2387